Approved vs adjudicated, you are correct. We'll all know soon enough. Either way, Q3 should look impressive. And when PIMD and eventually RapiMeds are factored in, the numbers will even look better. We are in great shape, unfortunately the pps is not reflective of this tremendous success. It will correct itself soon.